行情

NVRO

NVRO

Nevro
NYSE

实时行情|Nasdaq Last Sale

135.46
+2.50
+1.88%
交易中 14:19 08/03 EDT
开盘
134.54
昨收
132.96
最高
136.18
最低
133.61
成交量
12.59万
成交额
--
52周最高
148.05
52周最低
60.51
市值
46.05亿
市盈率(TTM)
-49.9465
分时
5日
1月
3月
1年
5年

分析师评级

13位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测NVRO价格均价为139.56,最高价位170.00,最低价为116.00。

EPS

NVRO 新闻

更多
Why Nevro Corp (NVRO) Stock is a Compelling Investment Case
Brown Advisory recently released its Q2 2020 Investor Letter, a copy of which you can download here. The Small-Cap Growth Fund posted a return of 34.59% for the quarter, outperforming its benchmark, the Russell 2000 Growth Index which returned 30.59% in the sa
Insider Monkey · 3天前
Nevro (NVRO) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Nevro (NVRO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks · 5天前
­Nevro to Report Second Quarter 2020 Financial Results
Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that the Company will release its financial results for the second quarter ended June 30, 2020 a
PR Newswire · 07/20 11:00
Here's Why You Should Hold on to Nevro (NVRO) Stock Now
Investor confidence is high on Nevro (NVRO), thanks to solid prospects
Zacks · 07/10 12:46
Morgan Stanley Maintains Overweight on Nevro, Raises Price Target to $145
Morgan Stanley maintains Nevro (NYSE:NVRO) with a Overweight and raises the price target from $135 to $145.
Benzinga · 06/18 11:51
Edited Transcript of NVRO earnings conference call or presentation 5-May-20 8:30pm GMT
Thomson Reuters StreetEvents · 06/13 13:59
Edited Transcript of NVRO earnings conference call or presentation 25-Feb-20 9:30pm GMT
Q4 2019 Nevro Corp Earnings Call
Thomson Reuters StreetEvents · 06/08 16:33
UBS Upgrades Nevro to Neutral, Raises Price Target to $132
UBS analyst Matthew Taylor upgrades Nevro (NYSE:NVRO) from Sell to Neutral and raises the price target from $100 to $132.
Benzinga · 06/08 11:44

所属板块

医疗设备、用品及经销
+0.91%
医疗设备和用品
+1.26%

热门股票

代码
价格
涨跌幅

NVRO 简况

Nevro Corp.是一家医疗设备公司。该公司开发治疗慢性疼痛的神经调节平台,并将其商业化。该公司的Senza系统是提供HF10疗法的骨髓刺激系统。HF10疗法旨在提供治疗慢性疼痛的神经调节解决方案。HF10疗法缓解背部疼痛及腿部疼痛,在缓解疼痛的同时不造成知觉异常。该疗法对患者、医生及医院有益。Senza可以创造2赫兹到10千赫的电脉冲(包括HF10疗法)。HF10疗法输出10千赫脉搏率的电波。其程序设计算法经数据及临床验证。Senza由引线、试验刺激仪、植入式起搏器、手术工具、临床便携式编程设备、患者远程控制器及移动电源组成。
展开

微牛提供Nevro Corp(NYSE-NVRO)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的NVRO股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易NVRO股票基本功能。